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Background: During pediatric epilepsy surgery, due to low circulating blood volume, intraop-
erative bleeding can result in significant hemodynamic instability, thereby requiring meticu-
lous hemodynamic and transfusion strategies. Knowing the source of bleeding during the 
procedure would allow medical staff to better prepare the perioperative protocols for these 
patients. We compared intraoperative bleeding between the first (involving skin to menin-
ges) and second (involving brain parenchyma) stages of epilepsy surgery to investigate the 
differences between various anatomical sites. 
Methods: We reviewed the electronic medical records of 102 pediatric patients < 14 years 
old who underwent two-stage epilepsy surgeries during January 2012–December 2016. In-
vasive subdural grids were placed via craniotomy during Stage 1 and the epileptogenic zone 
was removed during Stage 2 of the surgery. We compared the volume of intraoperative 
bleeding between these two surgeries and identified variables associated with bleeding us-
ing multivariate regression analysis. 
Results: Both surgeries resulted in similar intraoperative bleeding (24 vs. 26 ml/kg, P = 
0.835), but Stage 2 required greater volumes of blood transfusion than Stage 1 (18.4 vs. 
14.8 ml/kg, P = 0.011). Massive bleeding was associated with patients < 7 years of age in 
Stage 1 and weighing < 18 kg in Stage 2. 
Conclusions: The volume of intraoperative bleeding was similar between the two stages of 
pediatric epilepsy surgery and was large enough to require blood transfusions. Thus, blood 
loss during pediatric epilepsy surgery occurred at both anatomic sites. This indicates the ne-
cessity of early preparation for blood transfusion in both stages of pediatric epilepsy surgery. 
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INTRODUCTION 
Intraoperative bleeding during pediatric craniotomy is 
challenging for anesthesiologists, with patients often re-
quiring blood transfusions due to their relatively low circu-
lating blood volume [1,2]. Although operation duration 
and patient age are known risk factors for the requirement 
of intraoperative blood transfusion during pediatric crani-
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otomy for brain tumor removal [1], there is little informa-
tion on the main source and volume of intraoperative 
bleeding. Thus, it is challenging for anesthesiologists to 
know when and how rheological management strategies 
should be applied in these patients. Understanding the 
characteristics of intraoperative bleeding from different 
anatomical sites during craniotomy would allow medical 
staff to establish appropriate perioperative strategies. 
For drug-resistant epilepsy, which comprises 20–30% of 
childhood epilepsy cases, patients have the option of one- 
or two-stage epilepsy surgeries [3–5]. In contrast to one-
stage surgery, the main surgical sites for two-stage surgery 
differ between the first and second stages. The first stage 
involves the implantation of subdural and/or strip elec-
trodes, and the procedures are mainly performed at the 
scalp, soft tissue, cranium, and meninges. The second 
stage is mainly performed at the brain parenchyma and in-
volves removing the epileptic foci or the epileptic transmis-
sion pathways [5,6]. Therefore, two-stage epilepsy surgeries 
could be good candidates for identifying the nature of in-
traoperative bleeding from different anatomical sites in 
and around the brain. 
In this study, we compared the intraoperative blood loss 
between the first and second stages of epilepsy surgery to 
investigate the bleeding properties of different anatomical 
sites and identify the associated variables during pediatric 
epilepsy surgeries. 
MATERIALS AND METHODS 
Ethics approval 
This retrospective study was approved by the Institution-
al Review Board (no. 4-2017-1030) on December 15, 2017. 
The requirement for written informed consent from pa-
tients was waived owing to the retrospective nature of the 
study. 
Patient population 
We reviewed the electronic medical records of pediatric 
patients (younger than 14 years) who underwent only two-
stage epilepsy surgeries between January 2012 and Decem-
ber 2016 at the university hospital. Patients were excluded 
if they underwent any surgical procedures beyond subdu-
ral electrode implantation during the first stage or if they 
underwent any operations due to complications or for oth-
er reasons between the two stages. 
Anesthesia 
Anesthesia was induced with 2 mg/kg propofol (Fresofol 
1% MCT, Fresenius Kabi Austria GmbH, Austria), 0.8 mg/
kg rocuronium (Rocumeron, Ilsung Pharmaceuticals Co., 
Ltd., Korea), and 0.5–1 µg/kg remifentanil (Ultian, Hanlim 
Pharm. Co., Ltd., Korea). Subsequently, a radial artery 
catheter was inserted, and an intravenous cannula (using a 
20-G or larger catheter) was placed in the peripheral or 
femoral vein. Anesthesia was maintained using sevoflurane 
in oxygen/air (50%) and remifentanil (0.05–0.15 µg/kg/
min). Electrocardiography, pulse oximetry, invasive arteri-
al blood pressure and esophageal temperature measure-
ment, capnography, and gas analysis were performed as 
standard monitoring. Allogeneic blood products were 
transfused at the discretion of the neuroanesthesiologist in 
charge of the patient, based on the patient’s intraoperative 
hemoglobin level, volume of blood loss, hemodynamic sta-
tus, and urinary output. After surgery, patients were extu-
bated and transferred to the neurosurgical intensive unit.  
Operation  
An invasive subdural grid and/or strip electrodes were 
placed via craniotomy during the Stage 1 surgery. Then, 
electrocorticography was performed for approximately 
7–10 days to identify the epileptic focus or epileptic trans-
mission pathways in preparation of Stage 2 surgery. During 
Stage 2, the intracranial electrodes were removed, and the 
epileptogenic zone or pathway of epilepsy transmission 
was resected. 
Variables 
Preoperative variables included demographics; anthro-
pometric data; duration and type of antiepileptic drugs 
(AEDs) received; skull thickness (largest cranial depth at 
the craniotomy performed at Stage 1, as detected on com-
puted tomography); and laboratory data before and after 
each surgery, such as hematocrit value, platelet count, co-
agulation test results (prothrombin time [PT], international 
normalized ratio [INR]), activated partial thromboplastin 
time (aPTT), serum calcium level, and levels of other elec-
trolytes (sodium, potassium, chloride, and phosphate). 
Perioperative variables consisted of the volumes of intra-
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Coperative bleeding and blood transfusions, operation dura-
tion, and hematocrit value immediately after surgery. The 
hematocrit level of the arterial blood gas test, conducted 
after anesthesia and after surgery, was used to calculate the 
volume of intraoperative bleeding. In Stage 1, total grid 
area was selected for surgical extent. Total grid area was 
defined as the sum of the area of the grid and that of the 
strip electrodes implanted. The surgical type and extent re-
quired for Stage 2 were investigated. Loss of more than 50% 
of the estimated blood volume was defined as massive 
bleeding [7,8]. 
Assessment of blood loss 
Blood loss (ml) was calculated using the following for-
mulas [9]: 
Estimated red cell volume (ERCV)lost =  ERCVpreop + ER-
CVtransfused – ERCVpostop 
ERCV =  estimated blood volume (EBV) ×  hematocrit val-
ue / 100 
The EBV (ml) was 80 ml/kg for infants younger than 12 
months and 75 ml/kg for children older than 12 months. 
The hematocrit value of the transfused packed red blood 
cells (PRBC) was 60%.  
ERCVtransfused =  (PRBC [ml])transfused ×  hematocrit valuetransfused 
PRBC / 100
The EBV was calculated as follows:
EBVlost (ml/kg) =  ERCVlost (ml) / [weight (kg) ×  hematocrit 
valuepreop / 100]
Statistical analyses 
All values are expressed as mean ±  standard deviation, 
median (1Q, 3Q), or number of patients (%). Normality was 
tested using the Kolmogorov–Smirnov and Shapiro–Wilk 
tests. Parametric data were analyzed using the paired t-test 
(aPTT); nonparametric data were analyzed using the Wil-
coxon signed-rank test (hematocrit, calcium, platelet, PT, 
operation duration, fluid intake, urine output, blood loss, 
and volume of transfusion). Categorical variables were 
evaluated using the McNemar’s test (incidence of massive 
bleeding). The volume of intraoperative bleeding was cal-
culated using the above-mentioned formulas, and the dif-
ferences between the two stages were analyzed. To identify 
variables associated with the volume of intraoperative 
bleeding, a multivariate linear regression model was used. 
A multivariate logistic regression model was used to identi-
fy variables associated with the incidence of massive 
bleeding. All preoperative variables (sex, age, height, 
weight, body mass index, body surface area, skull thick-
ness, duration of receiving AEDs, total grid area, hemato-
crit, calcium, platelet, PT, and aPTT) and operation dura-
tion were included in the regression analysis. The final lin-
ear and logistic regression models were determined using 
backward selection among significant variables in the mul-
tivariate regression with the enter method. In this analysis, 
the variables of height, body mass index, and body surface 
area, which were strongly related to the weight of the pedi-
atric patients, were excluded to reduce multicollinearity. 
The optimal cut-off value of the logistic regression analysis 
was calculated using the Youden index [10]. The predictive 
performance of the final model was quantified by the area 
under the curve with a 95% confidence interval. The Hos-
mer–Lemeshow test was used to assess goodness of fit for 
the logistic regression model. Correlation analyses were 
performed using the Pearson or Spearman methods. P val-
ue <  0.05 was considered to be statistically significant. All 
analyses were performed using SPSS version 23.0 (IBM 
Corp., USA) and MedCalc Statistical Software version 
18.11.3 (MedCalc Software bvba, Belgium).  
RESULTS 
During the study period, 109 pediatric patients (younger than 
14 years) underwent two-stage epilepsy surgeries (Fig. 1). Of 
these, four and three patients underwent subdural and epi-
dural hematoma removal, respectively, between Stage 1 and 
2. These patients were excluded, leaving a total of 102 pedi-
atric patients (median age, 7.3 years) to be studied. Preoper-
ative patient characteristics are presented in Table 1. The 
Stage 2 surgeries included frontal, temporal, parietal, or/
and occipital lobectomy; amygdalectomy; callosotomy; or/
and lesionectomy. The total grid area (mm2) in Stage 1 was 
112 (80, 128). Preoperative laboratory values and operative 
data are presented in Table 2. None of the patients reported 
elevated PT/aPTT or took anticoagulants. 
There were no statistical differences in the volume of in-
traoperative bleeding (24 vs. 26 ml/kg, P =  0.835) or in the 
incidence of massive bleeding (27% vs. 32%, P =  0.516) be-
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compared to that in Stage 1 (1.07 vs. 0.98, P <  0.001). The 
volume of blood transfusion (ml/kg) was higher in Stage 2 
than in Stage 1 (18.4 vs. 14.8, P =  0.011). None of the pa-
tients received fresh frozen plasma or platelet transfusions. 
Multivariate linear regression analysis showed that patient 
weight and operation duration were associated with blood 
loss during both surgery stages (Table 3). 
The variables associated with massive bleeding in Stage 
1 were age (cut-off value of 7.5 years) and PT (INR, cut-off 
value of 0.96); in Stage 2, the associated variables were 
weight (cut-off value of 18.1 kg) and PT (INR, cut-off value 
of 1.12) (Table 4). Receiver operating characteristics curve 
analysis of the aforementioned regression models predict-
ed intraoperative massive bleeding with an area under the 
curve of 0.803 (95% confidence interval, 0.712–0.875) 
during Stage 1 and 0.778 (95% confidence interval, 0.682–
0.857) during Stage 2. 
The duration of receiving AEDs was not correlated with 
preoperative PT or aPTT (P =  0.335 and P =  0.962, respec-
tively). 
DISCUSSION 
For pediatric patients undergoing craniotomy, careful 
planning of hemodynamic management and blood trans-
fusion strategies is required to avoid hypovolemia. In this 
study, we found that the volume of intraoperative bleeding 
was comparable between the two stages (i.e., Stage 1 vs. 2, 
involving the structures from the scalp to meninges vs. the 
brain parenchyma) of pediatric epilepsy surgery; however, 
Stage 2 required more blood transfusions than Stage 1. 
Massive bleeding during the surgery was associated with 
Table 1. Patient Characteristics (n = 102)
Variable Value
Male/Female 58/44
Age (yr) 7.3 (4.2, 11.1)
Height (cm) 122.0 (100.4, 143.8)
Weight (kg) 22.6 (16.3, 37.4)
Body mass index (kg/m2) 16.0 (15.1, 18.6)
Body surface area (m2) 0.89 (0.68, 1.24)
Skull thickness (mm) 11.0 (9.6, 14.0)
AED duration (mo) 40.0 (19, 75)
Values are presented as number of patients or median (1Q, 3Q). AED: 
antiepileptic drug.
Table 2. Preoperative Laboratory Values and Operative Data (n = 102)
Variable Stage 1 surgery Stage 2 surgery P value
Preoperative hematocrit (%) 33.9 (31.8, 35.7) 30.5 (28.2, 32.1) <  0.001
Preoperative calcium (mg/dl) 9.3 (9.0, 9.6) 8.8 (8.5, 9.2) <  0.001
Preoperative platelet (103/µl) 274 (223, 328) 271 (213, 325) 0.263
Preoperative PT (INR) 0.98 (0.94, 1.02) 1.07 (1.01, 1.12) <  0.001
Preoperative aPTT (s) 33.9 ±  4.1 30.1 ±  3.9 <  0.001
Operation duration (min) 200 (178, 235) 230 (200, 266) <  0.001
Fluid intake (ml/h) 371 (259, 514) 350 (263, 466) 0.074
Urine output (ml/h) 84 (46, 113) 84 (58, 121) 0.073
Blood loss (ml/kg) 24 (16, 38) 26 (13, 42) 0.835
 Percentage of blood loss relative to effective blood volume (%) 32 (21, 51) 39 (18, 59) 0.440
Transfusion of packed red blood cells by weight (ml/kg) 14.8 (6.6, 21.7) 18.4 (10.4, 26.7) 0.011
Massive blood loss 27 (27) 32 (31) 0.516
Values are presented as median (1Q, 3Q), mean ± SD, or number of patients (%). PT: prothrombin time, INR: international normalized ratio, aPTT: 
activated partial thromboplastin time, Massive blood loss: blood loss more than 50% of the estimated blood volume.
The patients who underwent 
the epilepsy surgery  
(n = 192) Excluded
• Age ≥ 14 years (n = 49)
• Patients who underwent 
the single stage of epilepsy 
surgery (n = 26)
• Patients who underwent 
resection of a brain 
parenchyma during the first 
stage surgery (n = 7)
• Incomplete data (n = 1)
Excluded
• Patients who underwent 
other surgical interventions 
between the two stages  
(n = 7)
The patients patients <14 
year of age who underwent 
two stages of epilepsy 
surgery (n = 109)
Patients finally included  
(n = 102)
Fig. 1. Flow chart of the medical record screening process.
tween the two surgery stages. Preoperative hematocrit val-
ues (%) and serum calcium levels (mg/dl) were lower in 
Stage 2 than in Stage 1 (30.5 vs. 33.9, P <  0.001; 8.8 vs. 9.3, P 
<  0.001). Preoperative PT (INR) was prolonged in Stage 2 
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Bleeding in pediatric epilepsy surgery
low body weight or young age and elevated PT. 
Timely preparation with adequate red blood cell vol-
umes has been challenging for anesthesiologists in the 
management of pediatric craniotomy. The study by 
Schmotzer et al. [11] regarding preoperative red blood cell 
preparation and utilization among pediatric surgical pro-
cedures revealed that the preparations of red blood cells 
for such procedures were much higher than its actual us-
age for transfusions. Interestingly, in their study, neurosur-
gery had a relatively lower ratio of red cell preparation to 
transfusion than other surgeries because intraoperative 
transfusion events were highest in neurosurgery, including 
epilepsy surgeries. However, Schmotzer et al. [11] did not 
mention whether the epilepsy surgeries were one- or two-
stage surgeries; thus, the information regarding the ana-
tomical source of bleeding or of the optimal timing for rhe-
ological management strategies in pediatric epilepsy sur-
geries could not be obtained. In our study, we observed 
that the Stage 1 surgery can induce significant intraopera-
tive bleeding, similar to levels seen in Stage 2. The signifi-
cance of our finding was highly evident for massive bleed-
ing; patient age <  7 years in Stage 1 and body weight <  18.1 
kg in Stage 2 were significant variables in addition to pro-
longed PT. Thus, blood loss during pediatric craniotomy 
occurred at both anatomical sites, from the skin to menin-
ges as well as from the brain parenchyma. Therefore, we 
recommend early preparation of red blood cells for trans-
fusion in patients who are less than 7 years of age or weigh-
ing less than 18 kg. 
Regarding the transfusion of red blood cells, we found 
that Stage 2 required larger volumes of blood transfusion 
than Stage 1, despite similar volumes of intraoperative 
bleeding. This difference in the volume of blood transfu-
sion between the two surgeries could be attributed to lower 
hematocrit values and serum calcium levels and to pro-
longed PT (INR) and operation durations associated with 
Stage 2 surgery. It is expected that young patients ( <  7 
years) undergoing craniotomy could be vulnerable to he-
modynamic instability before surgical manipulation at the 
brain parenchyma begins. In a previous study, brain tumor 
removal in children required 16 ml/kg of allogenic transfu-
sion [1]. This is comparable to the amount of allogenic 
transfusion required in epilepsy surgeries (14.8 and 18.4 
ml/kg in the first and second stages of epilepsy surgery in 
our study, respectively), despite the difference in the type 
of surgery, underlying pathology, age distribution, etc. [1]. 
Considering the requirement for a larger volume of blood 
transfusion during two-stage epilepsy surgeries, a special 
strategy—similar to that for pediatric cardiac surgery 
[12,13]—may be needed to enhance hematopoiesis using 
iron replacement or recombinant erythropoietin or to min-
imize intraoperative bleeding using antifibrinolytic agents 
[14,15]. 
As a second purpose of this study, we looked for the vari-
ables associated with volume of intraoperative bleeding in 
the first and second stages of surgeries. The duration of re-
ceiving AEDs and the skull thickness were statistically sig-
nificant for Stage 1 only in the univariate analysis, but they 
were insignificant in the multivariate analysis. Indeed, it is 
uncertain whether AEDs thicken the skull and increase 
bleeding tendency due to their effects on bone metabo-
lism, bone matrix calcium, and platelet fraction [16,17]. Pe-
diatric patients taking AEDs such as carbamazepine, phe-
nytoin, and valproic acid have been shown to exhibit 
thrombocytopenia and severe intraoperative bleeding [18–
20]. In addition, valproic acid and gabapentin are associat-
ed with acquired von Willebrand disease type 1, hypofi-
brinogenemia, decreased factor XIII, and abnormal plate-
let function [21–23]. However, Manohar et al. [24] failed to 
demonstrate the effects of AEDs on perioperative blood 
loss or coagulopathy. Besides this, the serum calcium level 
is a key cofactor in the coagulation cascade [25,26]. A low 
serum calcium level ( <  8.4 mg/dl) correlates with in-
creased bleeding and higher 30-day mortality rate in pa-
tients with intracranial hemorrhage compared to those in 
patients with normal serum calcium levels [27]. In the 
present study, the serum calcium level was associated with 
Stage 1 intraoperative bleeding only in the univariate anal-
ysis, but not in the multivariate analysis, and was not asso-
ciated with intraoperative and massive bleeding during 
Stage 2. In the multivariate regression analysis, the vari-
ables related to the volume of intraoperative bleeding in 
the two-stage epilepsy surgeries were the operation dura-
tion and patient body weight, which were comparable to 
the results reported previously [1]. 
Some limitations of our study should be acknowledged. 
First, this retrospective observational study was conducted 
at a single institute. Therefore, our results might not be ap-
plicable to patients from other institutes, given that surgical 
variables differ among different institutes and medical envi-
ronments. Second, we were not able to control the extent of 
surgery in this study, despite having measured total grid size 
for the size of surgical extent in Stage 1. During Stage 2, the 
operation sites were too diverse to categorize and analyze. 
288 www.anesth-pain-med.org





COther surgical variables, such as procedural proximity to 
vascularity at the surgical site, could be associated with in-
traoperative bleeding during craniotomy for epilepsy sur-
gery, regardless of the stage. We could not measure these 
additional variables owing to the retrospective nature of the 
study. Third, participants were recruited over a long period 
of time, during which the AED regimen may have changed. 
Fourth, the Stage 2 surgeries were performed 7–10 days after 
Stage 1, and the status of red cell mass as well as coagulation 
profiles during Stage 2 were likely affected by the immediate 
postoperative status of Stage 1. 
In conclusion, the volume of intraoperative bleeding in 
the first and second stages of two-stage epilepsy surgeries 
was similar and significant enough to require blood trans-
fusion. This indicates that the anatomical sites of intraop-
erative bleeding during pediatric epilepsy surgery were 
both from the skin to the meninges as well as the brain pa-
renchyma. Therefore, early preparation for blood transfu-
sion is needed in pediatric patients undergoing the two 
stages of epilepsy surgery, especially in patients who are <  
7 years of age or weighing <  18 kg. 
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